QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial

Knight Therapeutics (GUD) News Today

→ The #1 Opportunity of the decade? (From Behind the Markets) (Ad)
Free GUD Stock Alerts
C$5.72
-0.07 (-1.21%)
(As of 04:00 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades
SourceHeadline
msn.com logoTSX Healthcare in April 2024: The Best Stocks to Buy Right Now
msn.com - April 16 at 5:45 PM
insidertrades.com logoKnight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Sells 10,900 Shares
insidertrades.com - April 16 at 4:40 AM
marketbeat.com logoSime Armoyan Sells 10,900 Shares of Knight Therapeutics Inc. (TSE:GUD) Stock
marketbeat.com - April 15 at 10:58 AM
marketbeat.com logoKnight Therapeutics (TSE:GUD) Reaches New 1-Year High at $5.80
marketbeat.com - April 10 at 2:51 PM
finance.yahoo.com logoKnight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
finance.yahoo.com - April 9 at 8:17 AM
insidertrades.com logoKnight Therapeutics Inc. (TSE:GUD) Insider Buys C$32,550.00 in Stock
insidertrades.com - April 9 at 4:48 AM
marketbeat.com logoInsider Buying: Knight Therapeutics Inc. (TSE:GUD) Insider Purchases 6,200 Shares of Stock
marketbeat.com - April 8 at 11:48 AM
insidertrades.com logoKnight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Acquires 351,000 Shares
insidertrades.com - March 26 at 4:18 AM
marketbeat.com logoKnight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Buys 351,000 Shares
marketbeat.com - March 25 at 6:22 PM
investing.com logoEarnings call: Knight Therapeutics announced record revenues of $343 million
investing.com - March 23 at 3:55 PM
marketbeat.com logoRoyal Bank of Canada Raises Knight Therapeutics (TSE:GUD) Price Target to C$7.00
marketbeat.com - March 22 at 2:31 PM
finance.yahoo.com logoKnight Therapeutics Full Year 2023 Earnings: Misses Expectations
finance.yahoo.com - March 22 at 7:22 AM
ca.finance.yahoo.com logoKnight Therapeutics Inc (04K.SG)
ca.finance.yahoo.com - March 20 at 7:00 PM
ca.finance.yahoo.com logoStocks in play: Knight Therapeutics Inc.
ca.finance.yahoo.com - March 14 at 12:54 PM
marketbeat.com logoRaymond James Research Analysts Increase Earnings Estimates for Knight Therapeutics Inc. (TSE:GUD)
marketbeat.com - March 8 at 7:22 AM
finance.yahoo.com logoFavourable Signals For Knight Therapeutics: Numerous Insiders Acquired Stock
finance.yahoo.com - March 7 at 8:15 AM
marketbeat.com logoAnalysts Offer Predictions for Knight Therapeutics Inc.'s Q4 2023 Earnings (TSE:GUD)
marketbeat.com - March 1 at 6:36 AM
ca.finance.yahoo.com logoStocks in play: Knight Therapeutics Inc.,
ca.finance.yahoo.com - February 29 at 2:45 PM
msn.com logoKnight Therapeutics launches Minjuvi in Brazil
msn.com - February 29 at 9:44 AM
marketbeat.com logoBrokers Issue Forecasts for Knight Therapeutics Inc.'s FY2023 Earnings (TSE:GUD)
marketbeat.com - February 29 at 7:39 AM
finance.yahoo.com logoKnight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil
finance.yahoo.com - February 21 at 8:54 PM
marketbeat.com logoInsider Selling: Knight Therapeutics Inc. (TSE:GUD) Insider Sells 28,200 Shares of Stock
marketbeat.com - January 23 at 1:54 PM
marketbeat.com logoKnight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Sells 91,000 Shares
marketbeat.com - January 22 at 2:42 PM
finance.yahoo.com logoKnight Therapeutics Announces Product Launch for IMVEXXY® in Canada
finance.yahoo.com - January 4 at 8:34 AM
finance.yahoo.com logoKnight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree® (viloxazine) in Canada
finance.yahoo.com - December 19 at 7:42 AM
finance.yahoo.com logoKnight Therapeutics Inc. places No. 90 on The Globe and Mail's fifth-annual ranking of Canada's Top Growing Companies
finance.yahoo.com - October 2 at 5:46 PM
theglobeandmail.com logoClosing Bell: Knight Therapeutics Inc flat on Thursday (GUD)
theglobeandmail.com - September 14 at 5:50 PM
markets.businessinsider.com logoKnight Therapeutics (KHTRF) Receives a Buy from RBC Capital
markets.businessinsider.com - August 12 at 11:28 PM
theglobeandmail.com logoTrading For This Specialty Pharma Company is up Following Second Quarter Results
theglobeandmail.com - August 10 at 12:47 PM
finance.yahoo.com logoKnight Therapeutics Reports Second Quarter 2023 Results
finance.yahoo.com - August 10 at 7:46 AM
finance.yahoo.com logoNotice of Knight Therapeutics' Second Quarter 2023 Results Conference Call
finance.yahoo.com - August 3 at 8:40 PM
theglobeandmail.com logoClosing Bell: Knight Therapeutics Inc up on Tuesday (GUD)
theglobeandmail.com - June 7 at 1:52 AM
finance.yahoo.com logoKnight to Present at the Jefferies 2023 Healthcare Conference in New York City
finance.yahoo.com - June 2 at 8:29 AM
theglobeandmail.com logoClosing Bell: Knight Therapeutics Inc down on Wednesday (GUD)
theglobeandmail.com - May 31 at 9:25 PM
finance.yahoo.com logoSamira Sakhia Bought 12% More Shares In Knight Therapeutics
finance.yahoo.com - May 26 at 8:59 AM
finance.yahoo.com logoSamira Sakhia Bought 12% More Shares In Knight Therapeutics \
finance.yahoo.com - May 26 at 8:59 AM
finance.yahoo.com logoShareholders in Knight Therapeutics (TSE:GUD) are in the red if they invested five years ago
finance.yahoo.com - May 23 at 9:41 AM
theglobeandmail.com logoClosing Bell: Knight Therapeutics Inc down on Monday (GUD)
theglobeandmail.com - May 8 at 7:14 PM
finance.yahoo.com logoNotice of Knight Therapeutics' First Quarter 2023 Results Conference Call
finance.yahoo.com - May 4 at 7:37 AM
theglobeandmail.com logoClosing Bell: Knight Therapeutics Inc down on Friday (GUD)
theglobeandmail.com - April 28 at 6:49 PM
finance.yahoo.com logoKnight to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
finance.yahoo.com - April 18 at 8:31 AM
theglobeandmail.com logoClosing Bell: Knight Therapeutics Inc up on Monday (GUD)
theglobeandmail.com - April 10 at 7:05 PM
marketwatch.com logoKnight Therapeutics Inc. ranks on The Globe and Mail's fourth-annual Women Lead Here benchmark of executive gender diversity
marketwatch.com - March 25 at 7:52 AM
marketbeat.com logoKnight Therapeutics (TSE:GUD) Given New C$6.00 Price Target at National Bankshares
marketbeat.com - March 24 at 2:24 PM
finance.yahoo.com logoKnight Therapeutics Reports Fourth Quarter and Year-End 2022 Results
finance.yahoo.com - March 23 at 8:05 AM
benzinga.com logoKnight Therapeutics Stock (OTC:KHTRF), Quotes and News Summary
benzinga.com - February 28 at 6:49 PM
nypost.com logoSpielberg: ‘Dark Knight’ should’ve been Oscars’ first Best Picture blockbuster
nypost.com - January 27 at 7:02 PM
msn.com logoWayne Knight Claims Seinfeld 'Obliterated' His Film Career
msn.com - January 18 at 11:09 PM
finance.yahoo.com logoBullish insiders bet CA$2.9m on Knight Therapeutics Inc. (TSE:GUD)
finance.yahoo.com - November 8 at 3:42 PM
marketbeat.com logoKnight Therapeutics Inc. to Post FY2022 Earnings of $0.26 Per Share, National Bank Financial Forecasts (TSE:GUD)
marketbeat.com - November 7 at 1:32 AM
Get Knight Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUD and its competitors with MarketBeat's FREE daily newsletter.

Will this $2 AI stock double overnight? (Ad)

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>

GUD Media Mentions By Week

GUD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GUD
News Sentiment
▼
0.59

0.52
▲
Average
Medical
News Sentiment

GUD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GUD Articles
This Week
▼
4

0
▲
GUD Articles
Average Week

Get Knight Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (TSE:GUD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Your Money is Not Safe
American Alternative
SHOCKING Crypto Leak…
Crypto 101 Media